Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.9%

16 terminated/withdrawn out of 846 trials

Success Rate

92.2%

+5.7% vs industry average

Late-Stage Pipeline

10%

83 trials in Phase 3/4

Results Transparency

3%

6 of 189 completed trials have results

Key Signals

205 recruiting6 with results6 terminated10 withdrawn

Enrollment Performance

Analytics

N/A
248(43.4%)
Phase 2
131(22.9%)
Phase 1
102(17.8%)
Phase 3
48(8.4%)
Phase 4
35(6.1%)
Early Phase 1
8(1.4%)
572Total
N/A(248)
Phase 2(131)
Phase 1(102)
Phase 3(48)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (846)

Showing 20 of 846 trials
NCT06146946Not ApplicableRecruiting

Safety of Mid and Low Rectal Cancer Surgery Without Dissection of the No.253 Lymph Node (S-M-O-O-T-H)

Role: collaborator

NCT07738159Phase 2Not Yet Recruiting

Iparomlimab and Tuvonralimab (QL1706) Plus Lenvatinib and Chemotherapy for Extrapulmonary Neuroendocrine Carcinoma

Role: lead

NCT07040943Phase 1Completed

Clinical Trial of IL - 22BP Safety, Tolerability, and Antitumor Activity in Refractory Solid Tumors.

Role: lead

NCT07733492Not ApplicableNot Yet Recruiting

Rehabilitation With Wearable Monitors for Post-Lung Cancer Surgery

Role: lead

NCT07409805Phase 1Recruiting

YMN-136 Vaccine for Patients With Liver Metastasis of Colorectal Cancer Progressing After Third-Line Treatment

Role: lead

NCT07572812Phase 1Not Yet Recruiting

A Phase I Clinical Trial of UX-GIP001 in the Treatment of Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy

Role: collaborator

NCT06509919Suspended

Application of a Novel Model Based on Plasma cfDNA Assay and MRl Imaging in the Detection of Prostate Cancer

Role: collaborator

NCT06589154Completed

The Application of Multimodal Artificial Intelligence Systems in Prostate Cancer Diagnosis and Prognosis Analysis

Role: collaborator

NCT07724106Phase 1Not Yet Recruiting

A Single-Arm, Open-Label, Prospective Study Evaluating the Safety, Tolerability, and Immunogenicity of the NeoOVSV Vaccine in Patients With Ovarian Cancer After Surgery

Role: lead

NCT06798363Phase 2Recruiting

Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma

Role: lead

NCT07716423Not ApplicableNot Yet Recruiting

Remote Versus On-Site Robotic Surgery for Hepatobiliary and Pancreatic Procedures

Role: lead

NCT07715279Phase 2Not Yet Recruiting

Vericiguat for the Inhibition of Calcific Aortic Valve Stenosis Progression

Role: lead

NCT05824923Phase 3Active Not Recruiting

A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure

Role: collaborator

NCT07622199Not ApplicableRecruiting

PROfunda Femoris Vein Thrombosis Evaluation and Clearance to Improve Outcomes of Endovascular Treatment for Acute Iliofemoral Deep Vein Thrombosis

Role: collaborator

NCT07718126Phase 2Not Yet Recruiting

Pre-hepatectomy Rehabilitation in Obese MASLD-Complicated Living Liver Donors With Mazdutide (PRIME)

Role: lead

NCT04462172Not ApplicableCompleted

A Prospective Multicenter Cohort Study About Internal Fixation Using FNS Versus MCS for Femoral Neck Fracture

Role: collaborator

NCT07715565Phase 2Not Yet Recruiting

Ipilimumab N01 Plus Sintilimab and Lenvatinib as First-line Therapy for Locally Advanced or Metastatic TFE3-Rearranged Renal Cell Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Clinical Trial

Role: lead

NCT07672210Recruiting

PregnAncy-Related Aortic DISsEction in China

Role: collaborator

NCT07398664Phase 2Recruiting

H101 Plus TACE for r/m HNSCC

Role: lead

NCT07707076Not ApplicableRecruiting

Flow Diverter Versus Conventional Endovascular Treatment for Unruptured Wide-Neck Bifurcation Aneurysms (FD-BWA Trial)

Role: collaborator